Banka Bioloo Limited Stock Beneish M Score

BANKA Stock   101.35  1.44  1.40%   
This module uses fundamental data of Banka BioLoo to approximate the value of its Beneish M Score. Banka BioLoo M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Banka BioLoo Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
At this time, Banka BioLoo's Short and Long Term Debt Total is very stable compared to the past year. As of the 22nd of December 2024, Net Debt is likely to grow to about 268.8 M, while Long Term Debt Total is likely to drop about 50.5 M.
At this time, Banka BioLoo's M Score is inapplicable. The earnings manipulation may begin if Banka BioLoo's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Banka BioLoo executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Banka BioLoo's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.17
Beneish M Score - Inapplicable
Elasticity of Receivables

1.7

Focus
Asset Quality

2.11

Focus
Expense Coverage

0.9

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

0.9

Focus
Depreciation Resistance

1.0

Focus
Net Sales Growth

0.56

Focus
Financial Leverage Condition

1.0

Focus

Banka BioLoo Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Banka BioLoo's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables25.6 M27 M
Notably Down
Slightly volatile
Total Revenue279.2 M500 M
Way Down
Slightly volatile
Total Assets812.9 M774.2 M
Sufficiently Up
Slightly volatile
Total Current Assets255.8 M493.4 M
Way Down
Slightly volatile
Non Current Assets Total294.9 M280.8 M
Sufficiently Up
Slightly volatile
Property Plant Equipment165.4 M157.6 M
Sufficiently Up
Slightly volatile
Depreciation And Amortization23 M21.9 M
Sufficiently Up
Slightly volatile
Selling General Administrative4.5 M8.9 M
Way Down
Slightly volatile
Total Current Liabilities266.2 M253.5 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total129.3 M123.1 M
Sufficiently Up
Slightly volatile
Net Debt268.8 M256 M
Sufficiently Up
Slightly volatile
Short Term Debt152.5 M145.3 M
Sufficiently Up
Slightly volatile
Long Term Debt114.6 M109.1 M
Sufficiently Up
Slightly volatile
Operating Income31.4 M17.4 M
Way Up
Slightly volatile
Short Term Investments21 M13.8 M
Way Up
Slightly volatile

Banka BioLoo Limited Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Banka BioLoo's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Banka BioLoo in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Banka BioLoo's degree of accounting gimmicks and manipulations.

About Banka BioLoo Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

22.98 Million

At this time, Banka BioLoo's Depreciation And Amortization is very stable compared to the past year.

Banka BioLoo Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Banka BioLoo. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables264.2M233.9M50.2M306.9M27.0M25.6M
Total Revenue478.7M304.6M387.5M423.5M500.0M279.2M
Total Assets467.7M463.7M640.5M652.1M774.2M812.9M
Total Current Assets345.4M360.1M525.8M414.8M493.4M255.8M
Net Debt113.5M98.8M181.8M158.7M256.0M268.8M
Short Term Debt19.9M48.8M93.9M106.5M145.3M152.5M
Long Term Debt74.1M58.7M74.3M49.4M109.1M114.6M
Operating Income82.4M28.1M46.3M45.6M17.4M31.4M

About Banka BioLoo Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Banka BioLoo Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Banka BioLoo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Banka BioLoo Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Banka Stock

Banka BioLoo financial ratios help investors to determine whether Banka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Banka with respect to the benefits of owning Banka BioLoo security.